The latest notice of the two departments such as Hebei Provincial Health and Health Commission!

recently

Hebei Province Health and Health Commission,

Hebei Province Traditional Chinese Medicine Administration jointly released

Regarding further strengthening of medication safety management

Notice of improving the level of reasonable medication

Details are as follows

In order to further strengthen the safety management of medication, improve the level of reasonable medication, and protect the quality and safety of medical treatment and the right to people's health, in accordance with the National Health and Health Commission of the State Administration of Traditional Chinese Medicine, the "Notice on Further Strengthening the Safety Management of Drugs and Improvement of Reasonable Drugs" [2022] No. 122) Requirements, we will now make the following requirements for the safety management of medication in our province

01

Reduce the risk of errors in medication and improve the level of medication safety ‍

(1) Strengthen the implementation of the safety system of medication. Medical institutions should improve and implement the system of medication safety related systems, improve the consciousness and ability of medical care and other personnel, and standardize the full process management of prescriptions, deployment, administration, and medication. Physicians should open the correct, standardized, and appropriate prescription according to the patient's condition; pharmacists shall conscientiously fulfill the prescription audit duties in accordance with the requirements of the "Medical Institution Prescription Review Code", and all prescriptions and drug use doctors can be charged and distributed after passing the review; Medical personnel such as the doctor's order should strictly implement the "three checks and seven pairs" to ensure that the time, approach, dose of dosage, and dosage of administration must be correct. Encourage medical institutions to use informatization methods to intelligently review and manage the entire process of clinical medication.

(2) Strengthen the management of key drugs. Medical institutions should establish high -warning drugs and easy to confuse drug management systems. For high -warning drugs and multiple specifications, seemingly, and easy -to -listen to confusing drugs in the institution, they are stored and set up warning signs. Strengthen the training of medical staff to make it accurately identify; when the medicine is allocated and distributed, the medical staff should remind each other to do a good job of medical education for patients and pay attention to the misuse of misuse. Take comprehensive measures to control the use of antibacterial drugs and the use of antibacterial drugs for patients in patients in a reasonable range, and the use intensity of antibacterial drugs is controlled below 40ddd/100 people. At the same time, timely adjust the hierarchical management directory of key monitoring drugs and antibacterial drugs, and strengthen the use of key monitoring drugs, anti -microbiological drugs, anti -tumor drugs, proton pump inhibitors, glucocorticoids, poisonous spermic drugs, Chinese medicine injection, etc. manage. Through the monitoring of blood concentration, genetic testing, etc., identify the risk of medication, formulate individualized medication solutions, optimize variety selection, and accurately determine the dose of medication.

(3) Safety safety for key groups. Medical institutions should strengthen the safety management of medication for the elderly, children, and maternals. Establish a system of medication for elderly patients, take hierarchical management measures for elderly patients at different levels of risks, strengthen medication and reminds of medication, and avoid wrong medicines. When selecting children's medicines (limited to drugs in the drug instructions, there are medicines with a clear certificate of child adaptation and children's dosage), they may not be limited by the "one product and two regulations" and the total number of pharmaceutical varieties. In response to the characteristics of maternal mothers, we must strengthen the management of all aspects of medication, focus on the use of cautious medicines for maternals, and strive to achieve "minimum effective dosage, minimum effective treatment, minimum poison side effects", to maximize the impact on maternal and fetus.

02

Strengthen monitoring reports and analysis, actively respond to adverse drug reactions

(4) Monitoring reports on adverse drug reactions. Medical institutions should monitor reports in accordance with relevant regulations such as the "Measures for the Advance Report and Monitoring and Management Measures", and make a good monitoring report for adverse drug reactions, clarify that specialized personnel actively collect the adverse reactions of drugs, and report to the relevant departments in a timely manner in accordance with the principle of "suspicious reports". Information, improve the number and quality of the report. Establishing and preserving the adverse reactions reports and monitoring files, drugs with many adverse reactions and outstanding safety hazards shall be promptly exited in accordance with the law and regulations.

(5) Strengthen the analysis and disposal of monitoring results. Medical institutions should carefully statistically analyze the report and monitoring data of drug adverse reactions, propose targeted improvement goals, and take effective measures to reduce and prevent repetition of adverse drug reactions. After the medical institutions have discovered a serious adverse reaction, they should be suspended and actively cure patients while reporting according to regulations. The pharmacy department immediately conducts pharmaceutical traceability and quality assessment, investigate the causes, and observe and record; after evaluation, determine whether to continue to use or replace the drug.

(6) Research and judge the risk of medication in a timely manner and feedback clinical. Medical institutions should pay close attention to the monitoring information of adverse reactions released by relevant national and provincial departments, industry academic associations, and authoritative academic journals. Adverse reactions to evaluate drug safety. The analysis and evaluation situation is promptly fed back to the clinic in time, and the role of warning reminders is given full play, and the formation of adverse reactions is derived from a virtuous cycle of clinical and serving clinical.

03

Strengthen the safety supervision of medication and promote the improvement of reasonable medication levels

(7) Implement the main responsibility of medical institutions. Medical institutions should strengthen the supervision and management of the standardized behavior of physicians' practice, and ensure that they are reasonably standardized for prescriptions in accordance with the clinical diagnosis and treatment guidelines, clinical application guidance principles and clinical paths, national prescription sets, and drug manuals. Medical institutions must conscientiously implement the requirements of the "Medical Institution Prescription Review Specifications", and regularly organize the prescription review team to comment on the prescription doctor's order in accordance with a certain proportion. No less than 100 photos; no less than 1%of the ward (district) doctor's order (according to the number of medical records in the hospital), and the absolute number of medical records for the hospitalization of hospitalization is not less than 30. It is necessary to carefully analyze the problems existing in the reviews, find specific reasons, put forward suggestions for quality improvement, study and formulate targeted improvement measures, implement them one by one, and include the results of the reviews and their staff performance assessment and annual assessment indicators. Vigorously carry out the training of clinical pharmacists to actively provide conditions for clinical pharmacists to participate in training to ensure corresponding treatment. (8) Establish and improve a reward and punishment mechanism. Health and health administrative departments at all levels (including the competent Chinese medicine department) should be adjusted and updated in accordance with the adjustment and renewal of clinical medication related specifications, guidelines, standards, etc., and timely do a good job of regular assessment of physicians. Make full use of the evaluation results of reasonable medication assessment, quality control target management, and prescription rational spot checks, and use important references for medical institutions and medical staff performance assessment, hospital review, medical regular assessment, evaluation and other work. Medical institutions with problems shall be dealt with seriously according to law; shall be punished for those who have leadership responsibilities and direct responsibilities; they shall praise and encourage medical institutions and personnel with outstanding performance.

(9) Continue to organize and implement it. All localities should further improve their ideological awareness, always promote the reasonable use of medical institutions in the prominent position, and adhere to the safety bottom line of medication. Non -public medical institutions such as private hospitals and individual clinics should be treated equally to strengthen business guidance and industry supervision. It is necessary to give full play to the professional organizational role of reasonable medication or medicine quality control, and strengthen professional technical support. The Provincial Health and Health Commission and the Provincial Traditional Chinese Medicine Bureau will organize to strengthen the promotion and regular notifications of work in various places, and adopt interviews and other methods for areas where work or management is poor to urge timely rectification and tracking and review.

Source: Hebei Health Commission Hebei Daily

Editor: Song Wei

- END -